Did you miss out on the recent hot IPOs for Noodles & Co. (Nasdaq: NDLS), Fairway Group Holdings (NYSE: FWM) and Stemline Therapeutics (Nasdaq: STML)?#-ad_banner-# Well, the hits keep on coming. Phillips 66 Partners (Nasdaq: PSXP), which was one of the looming initial public offerings that I profiled last week, surged a hefty 30% in its first day of trading. If you missed out on these fast starters, fret not. Many other recent IPOs haven’t fared nearly as well from their initial… Read More
Did you miss out on the recent hot IPOs for Noodles & Co. (Nasdaq: NDLS), Fairway Group Holdings (NYSE: FWM) and Stemline Therapeutics (Nasdaq: STML)?#-ad_banner-# Well, the hits keep on coming. Phillips 66 Partners (Nasdaq: PSXP), which was one of the looming initial public offerings that I profiled last week, surged a hefty 30% in its first day of trading. If you missed out on these fast starters, fret not. Many other recent IPOs haven’t fared nearly as well from their initial IPO price as these big gainers. IPOs sometimes need to simmer for a bit as investors only belatedly get around to checking them out. Here’s a quick look at what the hot money may have initially missed but far-sighted investors may soon start snapping up. 1. Esperion Therapeutics (Nasdaq: ESPR) Thanks to the blockbuster success of Lipitor and other statins, the cholesterol-fighting market has always been seen as a great prize for drug companies. Billions in sales await any drug… Read More